Company Filing History:
Years Active: 2010-2012
Title: Anuja Chattopadhyay: Innovator in Chemo-sensitivity Assays
Introduction
Anuja Chattopadhyay is a prominent inventor based in Pittsburgh, PA (US). She has made significant contributions to the field of oncology through her innovative work on chemo-sensitivity assays. With a total of two patents to her name, her research focuses on improving the monitoring and treatment of malignancies.
Latest Patents
Anuja's latest patents include advanced chemo-sensitivity assays that utilize tumor cells exhibiting persistent phenotypic characteristics. These assays represent an improved and unified system for monitoring the progression of individual patient malignancies. They are designed to identify cellular and secreted markers, screen cells for phenotypic and genotypic drift, and predict the chemotherapeutic response of patient tumor cells to various therapeutic agents. Furthermore, these systems allow for the monitoring and screening of multiple pharmaceutical agents for efficacy and long-term effects tailored to specific patients.
Career Highlights
Anuja Chattopadhyay is currently associated with Precision Therapeutics, Inc., where she continues to advance her research in cancer treatment. Her work has garnered attention for its potential to revolutionize how oncologists approach patient care.
Collaborations
Some of her notable coworkers include Michael J. Gabrin and Stacey Brower, who contribute to her research endeavors and the development of innovative solutions in the field.
Conclusion
Anuja Chattopadhyay's contributions to the field of oncology through her patented innovations in chemo-sensitivity assays highlight her role as a leading inventor. Her work not only enhances the understanding of tumor behavior but also paves the way for more effective cancer treatments.